313 related articles for article (PubMed ID: 19406144)
41. New aromatic esters of progesterone as antiandrogens.
Bratoeff E; Ramírez E; Flores E; Sánchez M; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):99-105. PubMed ID: 15449723
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
Silva-Ortiz AV; Bratoeff E; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
Bioorg Med Chem; 2015 Dec; 23(24):7535-42. PubMed ID: 26631442
[TBL] [Abstract][Full Text] [Related]
43. Molecular interactions of new pregnenedione derivatives.
Bratoeff E; Ramírez E; Flores E; Valencia N; Sánchez M; Heuze I; Cabeza M
Chem Pharm Bull (Tokyo); 2003 Oct; 51(10):1132-6. PubMed ID: 14519916
[TBL] [Abstract][Full Text] [Related]
44. Circulating levels of isoflavones and markers of 5alpha-reductase activity are higher in Japanese compared with New Zealand males: what is the role of circulating steroids in prostate disease?
Lewis JG; Nakajin S; Ohno S; Warnock A; Florkowski CM; Elder PA
Steroids; 2005 Dec; 70(14):974-9. PubMed ID: 16137729
[TBL] [Abstract][Full Text] [Related]
45. Benzo[c]quinolizin-3-ones: a novel class of potent and selective nonsteroidal inhibitors of human steroid 5alpha-reductase 1.
Guarna A; Machetti F; Occhiato EG; Scarpi D; Comerci A; Danza G; Mancina R; Serio M; Hardy K
J Med Chem; 2000 Oct; 43(20):3718-35. PubMed ID: 11020287
[TBL] [Abstract][Full Text] [Related]
46. Antiandrogenic effects of topically applied spironolactone on the hamster flank organ.
Weissmann A; Bowden J; Frank BL; Horwitz SN; Frost P
Arch Dermatol; 1985 Jan; 121(1):57-62. PubMed ID: 3155605
[TBL] [Abstract][Full Text] [Related]
47. Steroidal antiandrogens and 5alpha-reductase inhibitors.
Bratoeff E; Ramírez E; Murillo E; Flores G; Cabeza M
Curr Med Chem; 1999 Dec; 6(12):1107-23. PubMed ID: 10519917
[TBL] [Abstract][Full Text] [Related]
48. Enzymatic and binding activities of 5 alpha-reductase and androgen receptors in hamster prostate.
Cabeza M; Bratoeff E; Heuze I; Ramírez E; Sánchez M; Flores E
Proc West Pharmacol Soc; 2003; 46():128-31. PubMed ID: 14699908
[No Abstract] [Full Text] [Related]
49. Steroids and hematopoiesis. I. The effect of steroids on in vitro erythroid colony growth: structure/activity relationships.
Singer JW; Samuels AI; Adamson JW
J Cell Physiol; 1976 Jun; 88(2):127-34. PubMed ID: 1270518
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of sodium acetate incorporation into lipids by novel steroids in hamster flank organs.
Cabeza M; Heuze I; Bratoeff E; Ramirez E; Martinez R; Murillo E
Proc West Pharmacol Soc; 2001; 44():99-101. PubMed ID: 11794012
[No Abstract] [Full Text] [Related]
51. Local and systemic reduction by topical finasteride or flutamide of hamster flank organ size and enzyme activity.
Chen C; Puy LA; Simard J; Li X; Singh SM; Labrie F
J Invest Dermatol; 1995 Nov; 105(5):678-82. PubMed ID: 7594643
[TBL] [Abstract][Full Text] [Related]
52. Acid derivatives of benzisothiazole-1,1-dioxide as inhibitors of rat lens aldose reductase.
Da Settimo A; Primofiore G; La Motta C; Da Settimo F; Simorini F; Boldrini E; Bianchini P
Farmaco; 1996 Apr; 51(4):261-7. PubMed ID: 8645413
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and pharmacological evaluation of new steroidal 5 alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Flores E; Ramirez E; Quiroz A; Heuze I
Proc West Pharmacol Soc; 2002; 45():187-90. PubMed ID: 12434577
[No Abstract] [Full Text] [Related]
54. Dual inhibition of human leukocyte elastase and lipid peroxidation: in vitro and in vivo activities of azabicyclo[2.2.2]octane and perhydroindole derivatives.
Portevin B; Lonchampt M; Canet E; De Nanteuil G
J Med Chem; 1997 Jun; 40(12):1906-18. PubMed ID: 9191969
[TBL] [Abstract][Full Text] [Related]
55. Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid.
Liao S; Lin J; Dang MT; Zhang H; Kao YH; Fukuchi J; Hiipakka RA
Arch Dermatol Res; 2001 Apr; 293(4):200-5. PubMed ID: 11380153
[TBL] [Abstract][Full Text] [Related]
56. C(17,20)-lyase inhibitors. Part 2: design, synthesis and structure-activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C(17,20)-lyase inhibitors.
Matsunaga N; Kaku T; Ojida A; Tanaka T; Hara T; Yamaoka M; Kusaka M; Tasaka A
Bioorg Med Chem; 2004 Aug; 12(16):4313-36. PubMed ID: 15265485
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and pharmacological evaluation of 4-halo progesterone derivatives as antiandrogen.
Cabeza M; Quiroz A; Bratoeff E; Murillo ME; Ramírez E; Flores G
Chem Pharm Bull (Tokyo); 1999 Sep; 47(9):1232-6. PubMed ID: 10517005
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and 5α-reductase inhibitory activity of C₂₁ steroids having 1,4-diene or 4,6-diene 20-ones and 4-azasteroid 20-oximes.
Kim S; Kim YU; Ma E
Molecules; 2011 Dec; 17(1):355-68. PubMed ID: 22210173
[TBL] [Abstract][Full Text] [Related]
59. Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E
J Med Chem; 2003 Apr; 46(8):1419-28. PubMed ID: 12672241
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of levonorgestrel action on the flank organ and the sebaceous gland lipogenesis of female hamsters.
Cabeza M; Díaz de León L
Bol Estud Med Biol; 1993; 41(1-4):20-7. PubMed ID: 8074790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
